| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786685 | European Journal of Surgical Oncology (EJSO) | 2018 | 27 Pages |
Abstract
LFA is an oncologically safe strategy. Selection is a critical point, and the best results in terms of OS and DFS are observed in patients having radiological and pathological response to neoadjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Giammauro Berardi, Marc De Man, Stéphanie Laurent, Peter Smeets, Federico Tomassini, Riccardo Ariotti, Anne Hoorens, Jo van Dorpe, Oswald Varin, Karen Geboes, Roberto I. Troisi,